Expression of vascular endothelial growth factor receptors in human prostate cancer

By Ferrer F.A.   Miller L.J.   Lindquist R.   Kowalczyk P.   Laudone V.P.   Albertsen P.C.   Kreutzer D.L.  

Urology, Vol. 54, Iss. 3, 1999-09 ,pp. : 567-572

Elsevier

Access to resources Recommend Favorite

Vitamin E and the Y4 Agonist BA-129 Decrease Prostate Cancer Growth and Production of Vascular Endothelial Growth Factor

By Yu A.   Somasundar P.   Balsubramaniam A.   Rose A.T.   Vona-Davis L.   McFadden D.W.  

Journal of Surgical Research, Vol. 105, Iss. 1, 2002-06 ,pp. : 65-68

Academic Press

Access to resources Recommend Favorite

Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer

By Cvetkovic D.   Movsas B.   Dicker A.P.   Hanlon A.L.   Greenberg R.E.   Chapman J.D.   Hanks G.E.   Tricoli J.V.  

Urology, Vol. 57, Iss. 4, 2001-04 ,pp. : 821-825

Elsevier

Access to resources Recommend Favorite

Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer

By Duque J.L.F.   Loughlin K.R.   Adam R.M.   Kantoff P.W.   Zurakowski D.   Freeman M.R.  

Urology, Vol. 54, Iss. 3, 1999-09 ,pp. : 523-527

Elsevier

Access to resources Recommend Favorite

Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer

By Lin C.-C.   Wu H.-C.   Tsai F.-J.   Chen H.-Y.   Chen W.-C.  

Urology, Vol. 62, Iss. 2, 2003-08 ,pp. : 374-377

Elsevier

Access to resources Recommend Favorite